What are the risks and recovery expectations?

Common risks include injection site reactions, infusion reactions (e.g., fever, chills), and an increased susceptibility to infections due to immune suppression. Serious but rare risks include reactivation of latent infections, lymphoma, or drug-induced lupus. Recovery is outpatient-based; you can resume normal activities immediately after each dose, though fatigue or mild flu-like symptoms may occur for 1–2 days. Full therapeutic benefit typically emerges within 8–12 weeks, with ongoing monitoring to manage side effects.